1. Academic Validation
  2. Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein

Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein

  • FEBS Lett. 2004 Dec 17;578(3):239-44. doi: 10.1016/j.febslet.2004.10.094.
Ha-Na Woo 1 Gil-Sun Hong Joon-Il Jun Dong-Hyung Cho Hyun-Woo Choi Ho-June Lee Chul-Woong Chung In-Ki Kim Dong-Gyu Jo Jong-Ok Pyo John Bertin Yong-Keun Jung
Affiliations

Affiliation

  • 1 Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea.
Abstract

We have identified a novel CARD-containing protein from EST database. BinCARD (Bcl10-interacting protein with CARD). BinCARD was ubiquitously expressed. Co-immunoprecipitation, In vitro binding, mammalian two-hybrid, and immunostaining assays revealed that BinCARD interacted with Bcl10 through CARD. BinCARD potently suppressed NF-kappa B activation induced by Bcl10 and decreased the amounts of phosphorylated Bcl10. Mutations at the residue Leu17 or Leu65, which is highly conserved in CARD, abolished the inhibitory effects of BinCARD on both Bcl10-induced activation of NF-kappa B and phosphorylation of Bcl10. Further, expression of BinCARD inhibited Bcl10 phosphorylation induced by T cell activation signal. These results suggest that BinCARD interacts with Bcl10 to inhibit Bcl10-mediated activation of NF-kappa B and to suppress Bcl10 phosphorylation.

Figures